Pioneering ITK inhibition

Corvus Pharmaceutical 2022 R&D Symposium

Replay Available Here

We are passionate about designing new medicines to improve the lives of patients, headlined by a platform opportunity with ITK inhibition across cancer and immune diseases

learn more